Related Experiment Video
Updated: May 12, 2026
03:17
Static Strength Training Method for Type 2 Diabetic Mice
Published on: March 29, 2024
Type 2 diabetes sits in a chair.
1The Centre of Inflammation and Metabolism, Department of Infectious Diseases, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Diabetes, Obesity & Metabolism
|April 5, 2013
Summary
Type 2 diabetes (T2D) is rising globally. This review explores how sedentary behavior contributes to T2D development and worsening, suggesting reduced sitting time as a potential low-cost therapy.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Public Health
Background:
- Type 2 Diabetes (T2D) incidence is rapidly increasing worldwide, imposing significant healthcare burdens.
- Sedentary behavior, characterized by prolonged sitting time, is increasingly recognized as a major contributor to T2D.
- Current understanding emphasizes the link between reduced physical activity and T2D development and progression.
Purpose of the Study:
- To review the scientific evidence linking sedentary time to the development and exacerbation of Type 2 Diabetes.
- To explore the novel therapeutic potential of reducing sitting time for T2D management.
- To support the hypothesis that 'type 2 diabetes sits in a chair' through current scientific literature.
Main Methods:
- Comprehensive literature review of existing scientific studies on sedentary behavior and Type 2 Diabetes.
- Analysis of evidence connecting increased sitting time with T2D incidence and progression.
- Exploration of research questions regarding the efficacy of reducing sedentary time as a T2D treatment.
Main Results:
- Strong evidence indicates that increased sedentary time is a significant factor in the development of Type 2 Diabetes.
- Reduced physical activity, often accompanying sedentary behavior, exacerbates T2D conditions.
- The potential of reducing sitting time as an effective T2D treatment remains an under-examined but promising area.
Conclusions:
- Sedentary behavior is a critical, modifiable risk factor for Type 2 Diabetes.
- Reducing sitting time presents a potential low-cost, accessible strategy for T2D prevention and management.
- Further research is warranted to establish the therapeutic benefits of decreasing sedentary time in T2D patients.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...